PAVmed Provides Business Update and Third Quarter Financial

Lucid's quarterly revenue increased 392 percent sequentially
Veris Health commercial expansion efforts underway, with next-generation Veris Cancer Care Platform launching in Q4
Conference call and...

Related Keywords

Lishan Aklog , Source Pavmed Inc , Nasdaq , Pavmed Inc , Veris Health , Exchange Commission , Lucid Diagnostics Inc , Veris Health Inc , Veris Cancer Care Platform , Lucid Diagnostics , Chief Executive , Esoguard Esophageal , Medical Device Data System , Esophageal Cell Collection Device , Veris Cancer Care , Annual Report , Quarterly Report ,